The attachment
glycoprotein G of respiratory syncytial virus (RSV) is produced as both membrane-anchored and secreted forms by infected cells. Immunization with secreted RSV G (Gs) or
formalin-inactivated alumprecipitated RSV (FI-RSV) predisposes mice to immune responses involving a Th2 cell phenotype which results in more severe illness and pathology, decreased viral clearance, and increased
pulmonary eosinophilia upon subsequent RSV challenge. These responses are associated with increased
interleukin-4 (IL-4) production in FI-RSV-primed mice, and the responses are
IL-4 dependent.
RNase protection assays demonstrated that similar levels of
IL-4 mRNA were induced after RSV challenge in mice primed with vaccinia virus expressing Gs (vvGs) or a construct expressing only membrane-anchored G (vvGr). However, upon RSV challenge, vvGs-primed mice produced significantly greater levels of
IL-5 and
IL-13 mRNA and
protein than vvGr-primed mice. Administration of neutralizing anti-IL-4 antibody 11.B11 during vaccinia virus priming did not alter the levels of vvGs-induced
IL-5,
IL-13,
pulmonary eosinophilia, illness, or RSV titers upon RSV challenge, although
immunoglobulin G (
IgG) isotype profiles revealed that more
IgG2a was produced. vvGs-priming of IL-4-deficient mice demonstrated that G-induced airway
eosinophilia was not dependent on
IL-4. In contrast, airway
eosinophilia induced by FI-RSV priming was significantly reduced in IL-4-deficient mice. Thus we conclude that, in contrast to FI-RSV, the secreted form of RSV G can directly induce
IL-5 and
IL-13, producing
pulmonary eosinophilia and enhanced illness in RSV-challenged mice by an IL-4-independent mechanism.